Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 10401-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#10401-1-AP, RRID:AB_2085477
- Product name
- RAIDD antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated RAIDD antibody (Cat. #10401-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references PIDDosome-SCAP crosstalk controls high-fructose-diet-dependent transition from simple steatosis to steatohepatitis.
E2F-Family Members Engage the PIDDosome to Limit Hepatocyte Ploidy in Liver Development and Regeneration.
PIDDosome-induced p53-dependent ploidy restriction facilitates hepatocarcinogenesis.
The adaptor CRADD/RAIDD controls activation of endothelial cells by proinflammatory stimuli.
Cutting edge: the "death" adaptor CRADD/RAIDD targets BCL10 and suppresses agonist-induced cytokine expression in T lymphocytes.
Kim JY, Wang LQ, Sladky VC, Oh TG, Liu J, Trinh K, Eichin F, Downes M, Hosseini M, Jacotot ED, Evans RM, Villunger A, Karin M
Cell metabolism 2022 Oct 4;34(10):1548-1560.e6
Cell metabolism 2022 Oct 4;34(10):1548-1560.e6
E2F-Family Members Engage the PIDDosome to Limit Hepatocyte Ploidy in Liver Development and Regeneration.
Sladky VC, Knapp K, Soratroi C, Heppke J, Eichin F, Rocamora-Reverte L, Szabo TG, Bongiovanni L, Westendorp B, Moreno E, van Liere EA, Bakker B, Spierings DCJ, Wardenaar R, Pereyra D, Starlinger P, Schultze S, Trauner M, Stojakovic T, Scharnagl H, Fava LL, Foijer F, de Bruin A, Villunger A
Developmental cell 2020 Feb 10;52(3):335-349.e7
Developmental cell 2020 Feb 10;52(3):335-349.e7
PIDDosome-induced p53-dependent ploidy restriction facilitates hepatocarcinogenesis.
Sladky VC, Knapp K, Szabo TG, Braun VZ, Bongiovanni L, van den Bos H, Spierings DC, Westendorp B, Curinha A, Stojakovic T, Scharnagl H, Timelthaler G, Tsuchia K, Pinter M, Semmler G, Foijer F, de Bruin A, Reiberger T, Rohr-Udilova N, Villunger A
EMBO reports 2020 Dec 3;21(12):e50893
EMBO reports 2020 Dec 3;21(12):e50893
The adaptor CRADD/RAIDD controls activation of endothelial cells by proinflammatory stimuli.
Qiao H, Liu Y, Veach RA, Wylezinski L, Hawiger J
The Journal of biological chemistry 2014 Aug 8;289(32):21973-83
The Journal of biological chemistry 2014 Aug 8;289(32):21973-83
Cutting edge: the "death" adaptor CRADD/RAIDD targets BCL10 and suppresses agonist-induced cytokine expression in T lymphocytes.
Lin Q, Liu Y, Moore DJ, Elizer SK, Veach RA, Hawiger J, Ruley HE
Journal of immunology (Baltimore, Md. : 1950) 2012 Mar 15;188(6):2493-7
Journal of immunology (Baltimore, Md. : 1950) 2012 Mar 15;188(6):2493-7
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- K-562 cells were subjected to SDS PAGE followed by western blot with 10401-1-AP(CRADD antibody) at dilution of 1:1000
- Sample type
- cell line
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The RAIDD antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human RAIDD. This antibody recognizes human,mouse,rat antigen. The RAIDD antibody has been validated for the following applications: ELISA, WB, IHC analysis.